Dotbio
DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, its proprietary DotBody technology. DotBodies are domain therapeutic antibodies which are multi-specific, humanized and highly-stable. The company was founded by Professor Pär Nordlund and Dr. Ignacio Asial, who designed and conceptualized the DotBody technology based on their expertise in protein and antibody engineering at Singapore’s Nanyang Technological University. For more information visit
7-day free trial · no credit card
Verified contacts
18
available on Kipplo
LinkedIn employees
18
1 to 10 range
Open roles
—
no listings
Distinct roles
14
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 18 verified contacts at Dotbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
18 contacts with verified email or phone · masked until revealed.
- LK
Lui Ke Xin
Business Development Executive · Sales & Business Development
EmailPhone - AL
Akira Liu
VP, Corporate Development and Pipeline Management · Other
EmailPhone
Showing 2 of 18 verified contacts
Top roles at Dotbio
14 distinct titles indexed · top 10 shown.
- 2intern
- 2research associate
- 2scientist
- 1biomedical science graduate from ngee ann polytechnic hoping to enter r&d
- 1biomedical student at ngee ann polytechnic
- 1business development executive
- 1chief operating officer
- 1final year project (undergraduate researcher)
- 1msc student at leiden university
- 1project manager
- +4more titles
Sign up to unlock all 18 contacts at Dotbio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 18 verified contacts at Dotbio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.